
‘Gender transitioning’ males have 27x higher testicular cancer rate after using hormones: study
by
A peer-reviewed study found that males who used ’feminizing’ cross-sex hormones for more than two years were at massively heightened risk for testicular cancer, adding to a large body of evidence showing that ‘transitioning’ causes serious harms.
(LifeSiteNews) — A recent study found that males who had undergone prolonged female hormone or puberty blocker use as part of so-called “gender transitions” were nearly 27 times more likely to have developed testicular cancer.
As the authors of the peer-reviewed study note, “This study challenges previous assertions that there is no link between testicular cancer and hormone” use, highlighting the inadequacies in prior research methodologies.
In layman’s terms, males who received feminizing, cross-sex hormones for more than two years were at substantially heightened risk for testicular cancer.
While correlation does not necessarily indicate causation, the authors of the report suggest that this rise in incidence “may be due to long term pretreatment with hormones or blockers.”
“Transitioning” interventions, including puberty blockers, hormones, and surgeries, are never authentic medical treatments, as one’s immutable, God-given sex is not an illness.
The study looked at pathology reports on orchiectomy specimens — i.e., surgically removed testicles — undergone by males as part of their “gender transitioning” efforts.
“Unlike other studies in which patients underwent surgery after only 12 months of hormone [use], our investigation identified cancer in individuals on GAHT (‘Gender Affirming Hormone Therapy’) for more than 2 years,” wrote the researchers. “This suggests a potential heightened risk associated with prolonged hormone exposure.”
The researchers found that among the 458 cases investigated from January 1, 2018, to August 1, 2023, the incidence of germ cell tumors (GCRs) – the name assigned to tumors that grow within cells that develop into sperm or eggs – was found to be 26.5 times higher than that of the general population.
“With a growing number of adults identifying as transgender, and rates climbing each year, it is more important than ever to delineate the elements that increase cancer risk,” concluded the study.